Edwards Lifesciences receives FDA clearance for tricuspid valve repair device to treat severe symptomatic tricuspid regurgitation.

FDA expands import block, halting shipment of five Olympus endoscopes made in Japan after a June 2025 alert barred 58 devices over patient safety concerns.

Health providers argue developers should be accountable for safety of medical devices using generative artificial intelligence, not them, in recent comments to

Labcorp Myriad prenatal testing acquisition for $210M expands diagnostic capabilities with four key tests projected to generate $160M annually.

Intuitive’s U.S. robotic-surgery growth slowed to 10% in Q3 2025, marking the weakest pace since COVID-19, as CEO David Rosa shifts focus to broader adoption.

Physical AI is revolutionizing healthcare with real-world applications, enhancing patient care and medical efficiency.

Cigna partners with OpenAI to use AI for patients with complex illnesses like cancer, offering personalized support through clinical data and predictive insight

Humana leads Medicare Advantage ratings with 95% of members in four-star or higher plans, driving a 12% stock rise and beating J.P. Morgan’s forecast.

CMS enrollment cancellations recover $2.2B in taxpayer subsidies after canceling 315,000 ACA marketplace enrollments covering 760,000 individuals, according to

Cigna launches Health Sense to improve care access through personalized guidance using health data, coverage, and costs, with rollout starting early 2027 for ca